163 related articles for article (PubMed ID: 17596568)
21. Are myelodysplastic syndromes and acute myeloid leukemia one disease?
Gale RP; Bennett JM
Leuk Res; 2009 Mar; 33(3):351-4. PubMed ID: 18996594
[No Abstract] [Full Text] [Related]
22. IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation.
Nevill TJ; Shepherd JD; Sutherland HJ; Abou Mourad YR; Lavoie JC; Barnett MJ; Nantel SH; Toze CL; Hogge DE; Forrest DL; Song KW; Power MM; Nitta JY; Dai Y; Smith CA
Biol Blood Marrow Transplant; 2009 Feb; 15(2):205-13. PubMed ID: 19167680
[TBL] [Abstract][Full Text] [Related]
23. Therapy-related myeloid neoplasms: what's in a name?
Klimek VM; Tray NJ
Curr Opin Hematol; 2016 Mar; 23(2):161-6. PubMed ID: 26779614
[TBL] [Abstract][Full Text] [Related]
24. Myelodysplastic syndromes clinical practice guidelines in oncology.
Greenberg PL; Baer MR; Bennett JM; Bloomfield CD; De Castro CM; Deeg HJ; Devetten MP; Emanuel PD; Erba HP; Estey E; Foran J; Gore SD; Millenson M; Navarro WH; Nimer SD; O'Donnell MR; Saba HI; Spiers K; Stone RM; Tallman MS
J Natl Compr Canc Netw; 2006 Jan; 4(1):58-77. PubMed ID: 16403405
[No Abstract] [Full Text] [Related]
25. Bibliography. Current world literature. Leukemia.
Curr Opin Oncol; 2000 Jan; 12(1):B1-12. PubMed ID: 10687737
[No Abstract] [Full Text] [Related]
26. Evaluation of the prognostic relevance of L-selectin and ICAM1 expression in myelodysplastic syndromes.
Buccisano F; Maurillo L; Tamburini A; Del Poeta G; Del Principe MI; Ammatuna E; Consalvo MI; Campagna S; Ottaviani L; Sarlo C; Renzi D; Faccia S; Fraboni D; Lo Coco F; Amadori S; Venditti A
Eur J Haematol; 2008 Feb; 80(2):107-14. PubMed ID: 18028430
[TBL] [Abstract][Full Text] [Related]
27. Time to engraftment following allogeneic stem cell transplantation is significantly longer in patients with myelodysplastic syndrome than with acute myeloid leukemia.
Bitan M; Or R; Shapira MY; Resnick IB; Gesundheit B; Ackerstein A; Samuel S; Elad S; Slavin S
Bone Marrow Transplant; 2008 Jan; 41(1):69-78. PubMed ID: 17994125
[TBL] [Abstract][Full Text] [Related]
28. Outcome of patients with myelodysplastic syndromes: experience from a single institution in South Australia.
Hui CH; Horvath N; Lewis I; To LB; Szabo F
Intern Med J; 2008 Nov; 38(11):824-8. PubMed ID: 18284457
[TBL] [Abstract][Full Text] [Related]
29. The evolution of hematopoietic SCT in myelodysplastic syndrome.
Kindwall-Keller T; Isola LM
Bone Marrow Transplant; 2009 Apr; 43(8):597-609. PubMed ID: 19252532
[TBL] [Abstract][Full Text] [Related]
30. Treatment strategies in myelodysplastic syndromes.
Atallah E; Garcia-Manero G
Cancer Invest; 2008 Mar; 26(2):208-16. PubMed ID: 18259954
[TBL] [Abstract][Full Text] [Related]
31. Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia.
Raza A; Mehdi M; Mumtaz M; Ali F; Lascher S; Galili N
Cancer; 2008 Oct; 113(7):1596-604. PubMed ID: 18720364
[TBL] [Abstract][Full Text] [Related]
32. Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes.
Malcovati L
Leuk Res; 2007 Dec; 31 Suppl 3():S2-6. PubMed ID: 18037415
[TBL] [Abstract][Full Text] [Related]
33. [Myelodysplastic syndrome, a guide for clinical practice].
Suzuki T
Rinsho Ketsueki; 2013 Oct; 54(10):1671-81. PubMed ID: 24064816
[No Abstract] [Full Text] [Related]
34. Fanconi Anemia patient with AML1 gene amplification and monosomy 7 in pre-transplant myelodysplasia (MDS) relapsing 7 years after successful allo-SCT.
Ayas M; Walter C
Bone Marrow Transplant; 2008 Oct; 42(8):555-7. PubMed ID: 18622412
[No Abstract] [Full Text] [Related]
35. [Present and future prospects of MDS therapy].
Nakamura Y; Mitani K
Rinsho Ketsueki; 2013 Jan; 54(1):29-36. PubMed ID: 23391644
[No Abstract] [Full Text] [Related]
36. Farnesyltransferase inhibitors and their potential role in therapy for myelodysplastic syndromes and acute myeloid leukaemia.
Braun T; Fenaux P
Br J Haematol; 2008 May; 141(5):576-86. PubMed ID: 18410457
[TBL] [Abstract][Full Text] [Related]
37. A population-based study of survival in patients with secondary myelodysplastic syndromes (MDS): impact of type and treatment of primary cancers.
De Roos AJ; Deeg HJ; Davis S
Cancer Causes Control; 2007 Dec; 18(10):1199-208. PubMed ID: 17823848
[TBL] [Abstract][Full Text] [Related]
38. The myelodysplastic syndromes.
Nguyen PL
Hematol Oncol Clin North Am; 2009 Aug; 23(4):675-91. PubMed ID: 19577164
[TBL] [Abstract][Full Text] [Related]
39. Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes.
Neukirchen J; Blum S; Kuendgen A; Strupp C; Aivado M; Haas R; Aul C; Gattermann N; Germing U
Eur J Haematol; 2009 Nov; 83(5):477-82. PubMed ID: 19548919
[TBL] [Abstract][Full Text] [Related]
40. Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review.
Bernasconi P
Br J Haematol; 2008 Sep; 142(5):695-708. PubMed ID: 18540941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]